Techniques in Vascular & Interventional Radiology
Volume 13, Issue 1 , Pages 37-42 , March 2010

Treating the Diseased Superficial Femoral Artery

  • Jerry M. Gibbs, MD

      Affiliations

    • Department of Radiology, The Methodist Hospital, Endovascular Center, 6565 Fannin Street D281, Houston, TX
    • ,
  • Constantino S. Peña, MD

      Affiliations

    • Department of Interventional Radiology, Baptist Cardiac & Vascular Institute, Miami, FL
    • Corresponding Author InformationAddress reprint requests to Constantino S. Peña, MD, Baptist Cardiac & Vascular Institute, 8900 North Kendall Drive, Miami, FL
    • ,
  • James F. Benenati, MD

      Affiliations

    • Department of Interventional Radiology, Baptist Cardiac & Vascular Institute, Miami, FL

References 

  1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67
  2. Hertzer NR. The natural history of peripheral vascular disease (Implications for its management). Circulation. 1991;83(suppl):I12–I19
  3. Cox GS, Hertzer NR, Young JR, et al. Nonoperative treatment of superficial femoral artery disease: Long term follow up. J Vasc Surg. 1993;17:172–181discussion 181-182
  4. Spronk S, Bosch JL, den Hoed PT, et al. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: A randomized control trial. J Vasc Surg. 2008;48:1472–1480
  5. Taylor SM, Kalbaugh CA, Healy MG, et al. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? (A single center experience of 1,000 conservatively treated limbs). J Am Coll Surg. 2008;206:1053–1062discussion 1062-1064
  6. Rocha-Singh K, Jaff MR, Crabtree TR, et al. Performance goals and end point assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910–919
  7. Powell RJ. Endovascular treatment in the superficial femoral artery: Which devices, where?. Semin Vasc Surg. 2008;21:180–185
  8. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879–1888
  9. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–2749
  10. Katzen BT: The RESILIENT trial: Evidence for SFA stenting. Paper presented at: The British Society of Interventional Radiology Annual Meeting, 2009; Manchester Central, UK
  11. Duda SH, Puisch B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six month results. Circulation. 2002;106:1505–1509
  12. Duda SH, Bosiers M, Lammer J, et al. Sirolimas-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331–338
  13. Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol. 2008;19:823–832
  14. Kedora J, Hohmann S, Garrett W. Randomized comparison of percutaneous Viabahn stent grafts versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2007;45:10–16
  15. Mewissen MW. VIBRANT single center and multicenter results (VIBRANT trial) of viabahn stent-graft vs. uncovered nitinol stent for SFA occlusive disease. Paper presented at: The VEITH Symposium; November 20, 2008; New York, NY
  16. Bosiers M: MELOPEE-study: 12 month data—clinical duplex and Xray outcome of the lifestent in popliteal lesions. Paper presented at the International Symposium on Endovascular Therapy Annual Meet; January 22, 2008; Hollywood, FL
  17. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for treatment of atherosclerotic lesions in the superficial femoral artery: Long term results form the SIROCCO trial. J Endovasc Ther. 2006;13:701–710
  18. Siablis D, Kamabatidis D, Katsanos K, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: Enduring 1-year angiographic and clinical benefit. J Endovasc Ther. 2007;14:241–250
  19. Siablis D, Kamabatidis D, Katsanos K, et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: Midterm angiographic and clinical results. J Vasc Interv Radiol. 2007;18:1351–1361
  20. Karnabatidis D, Katsanos K, Kagadis GC, et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: An underestimated phenomenon. J Endovasc Ther. 2006;13:269–280

PII: S1089-2516(09)00068-7

doi: 10.1053/j.tvir.2009.10.005

Techniques in Vascular & Interventional Radiology
Volume 13, Issue 1 , Pages 37-42 , March 2010

Article Tools

* Image Usage & Resolution